Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

PLXDC1 antibody (C-Term)

PLXDC1 Reactivity: Human WB Host: Rabbit Polyclonal RB30617 unconjugated
Catalog No. ABIN1881662
  • Target See all PLXDC1 Antibodies
    PLXDC1 (Plexin Domain Containing 1 (PLXDC1))
    Binding Specificity
    • 12
    • 7
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 466-494, C-Term
    Reactivity
    • 35
    • 6
    • 6
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Human
    Host
    • 31
    • 4
    Rabbit
    Clonality
    • 32
    • 3
    Polyclonal
    Conjugate
    • 18
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This PLXDC1 antibody is un-conjugated
    Application
    • 26
    • 18
    • 6
    • 4
    • 3
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB)
    Purification
    This antibody is purified through a protein A column, followed by peptide affinity purification.
    Immunogen
    This PLXDC1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 466-494 amino acids from the C-terminal region of human PLXDC1.
    Clone
    RB30617
    Isotype
    Ig Fraction
    Top Product
    Discover our top product PLXDC1 Primary Antibody
  • Application Notes
    WB: 1:1000
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    4 °C,-20 °C
    Expiry Date
    6 months
  • Halder, Ossendorf, Maran, Yaszemski, Bolander, Fuchs, Sarkar: "Preferential expression of the secreted and membrane forms of tumor endothelial marker 7 transcripts in osteosarcoma." in: Anticancer research, Vol. 29, Issue 11, pp. 4317-22, (2009) (PubMed).

    Yamaji, Yoshida, Ishikawa, Sengoku, Sato, Yoshida, Kuwahara, Ohuchida, Oki, Enaida, Fujisawa, Kono, Ishibashi: "TEM7 (PLXDC1) in neovascular endothelial cells of fibrovascular membranes from patients with proliferative diabetic retinopathy." in: Investigative ophthalmology & visual science, Vol. 49, Issue 7, pp. 3151-7, (2008) (PubMed).

    Fuchs, Mahlum, Halder, Maran, Yaszemski, Bode, Bolander, Sarkar: "High expression of tumor endothelial marker 7 is associated with metastasis and poor survival of patients with osteogenic sarcoma." in: Gene, Vol. 399, Issue 2, pp. 137-43, (2007) (PubMed).

    Nanda, Buckhaults, Seaman, Agrawal, Boutin, Shankara, Nacht, Teicher, Stampfl, Singh, Vogelstein, Kinzler, St Croix: "Identification of a binding partner for the endothelial cell surface proteins TEM7 and TEM7R." in: Cancer research, Vol. 64, Issue 23, pp. 8507-11, (2004) (PubMed).

  • Target
    PLXDC1 (Plexin Domain Containing 1 (PLXDC1))
    Alternative Name
    PLXDC1 (PLXDC1 Products)
    Synonyms
    PLXDC1 antibody, TEM3 antibody, TEM7 antibody, 2410003I07Rik antibody, AI848450 antibody, Tem7 antibody, Arl12 antibody, plexin domain containing 1 antibody, PLXDC1 antibody, Plxdc1 antibody
    Background
    Plays a critical role in endothelial cell capillary morphogenesis.
    Molecular Weight
    55760
    NCBI Accession
    NP_065138
    UniProt
    Q8IUK5
You are here:
Support